Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Seminars in Cell & Developmental Biology|February 18, 2018
Dendritic cells as cancer therapeuticsChristian E Bryant, Sarah Sutherland, Benjamin Kong, et al.Brain Research|June 7, 2015
Midbrain dopamine neurons in Parkinson's disease exhibit a dysregulated miRNA and target-gene networkChristine E Briggs, Yulei Wang, Benjamin Kong, et al.Neurobiology of Aging|February 25, 2014
miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signalingWoori Kim, Yenarae Lee, Noah D McKenna, et al.The Journal of Infectious Diseases|May 25, 2011
Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in cultureSarmistha Bandyopadhyay, Robin C Friedman, Rebecca T Marquez, et al.Cancers|October 13, 2021
The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?Byeongsang Oh, Frances Boyle, Nick Pavlakis, et al.Clinical and Translational Science|January 20, 2018
Implementation of Standardized Clinical Processes for TPMT Testing in a Diverse Multidisciplinary Population: Challenges and Lessons LearnedKristin W Weitzel, D Max Smith, Amanda R Elsey, et al.BMJ Open|February 10, 2025
Low & Anaplastic Grade Glioma Umbrella Study of MOlecular Guided TherapieS (LUMOS-2): study protocol for a phase 2, prospective, multicentre, open-label, multiarm, biomarker-directed, signal-seeking, umbrella, clinical trial for recurrent IDH mutant, grade 2/3 gliomaKristen McParland, Eng-Siew Koh, Benjamin Kong, et al.Oncoimmunology|April 11, 2018
A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumor T cell responses at remissionJennifer L Hsu, Christian E Bryant, Michael S Papadimitrious, et al.Nature|April 16, 2010
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasisRajnish A Gupta, Nilay Shah, Kevin C Wang, et al.Journal of Leukocyte Biology|November 22, 2019
Distinguishing human peripheral blood CD16+ myeloid cells based on phenotypic characteristicsPhillip D Fromm, Pablo A Silveira, Jennifer L Hsu, et al.Pageof 2